Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery

Felipe F. Casanueva, Carlos Dieguez, Vera Popovic, Roberto Peino, Robert Considine, Jose F. Caro

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Leptin, the product of the ob gene, is a recently discovered hormone secreted by adipocytes. Serum leptin concentrations increase in correlation with the percentage of body fat, but besides that little is known about the physiological actions of leptin in humans. In order to understand the role of leptin in severe malnutrition, in the present work 10 patients recently diagnosed with anorexia nervosa were studied both before and 2 months later, after partial weight recovery, and were compared with 18 normal-weight women as controls. Leptin was measured by a newly developed radioimmunoassay and both IGF-I and IGFBP-3 were measured by commercial radioimmunoassays. The mean (±SE) serum leptin concentrations (in μg/liter) were 18.1 ± 2.0 in control women with BMI of 21.1 ± 0.3, significantly higher (P <0.01) than that in the anorexia nervosa patients at diagnosis (2.2 ± 0.1, BMI 15.3 ± 0.6). These differences were also observed in IGF-I values (μg/liter) that were 228.0 ± 14.6 in controls and 157.4 ± 28.7 in anorexia nervosa patients (P <0.02). No differences were observed in IGF-BP3. After treatment, patients with anorexia nervosa experienced an increase in BMI (17.1 ± 0.5, P <0.0001 vs before) although they were still underweight. The partial recovery in weight led to a complete normalization of IGF-I levels (214.0 ± 21.0 μg/liter) and to an enhancement in leptin levels (3.3 ± 0.5 μg/liter; P <0.03 vs before treatment), though still lower than those in normal- weight women (P <0.05). Individually analyzed, a large dispersion was observed in control subjects, with leptin levels ranging from 5.5 to 38.7 μg/liter, while in all anorexia nervosa patients leptin levels were under 3 μg/liter. A treatment-induced increase in body weight led to an increase.

Original languageEnglish (US)
Pages (from-to)116-120
Number of pages5
JournalBiochemical and Molecular Medicine
Volume60
Issue number2
DOIs
StatePublished - Apr 1997
Externally publishedYes

Fingerprint

Anorexia Nervosa
Leptin
Weights and Measures
Recovery
Serum
Insulin-Like Growth Factor I
Radioimmunoassay
Patient treatment
Insulin-Like Growth Factor Binding Protein 3
Thinness
Adipocytes
Malnutrition
Adipose Tissue
Therapeutics
Fats
Body Weight
Hormones

ASJC Scopus subject areas

  • Biochemistry

Cite this

Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery. / Casanueva, Felipe F.; Dieguez, Carlos; Popovic, Vera; Peino, Roberto; Considine, Robert; Caro, Jose F.

In: Biochemical and Molecular Medicine, Vol. 60, No. 2, 04.1997, p. 116-120.

Research output: Contribution to journalArticle

Casanueva, Felipe F. ; Dieguez, Carlos ; Popovic, Vera ; Peino, Roberto ; Considine, Robert ; Caro, Jose F. / Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery. In: Biochemical and Molecular Medicine. 1997 ; Vol. 60, No. 2. pp. 116-120.
@article{b6fbb7d0f1ea4fab9ed4d051cf3c34a6,
title = "Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery",
abstract = "Leptin, the product of the ob gene, is a recently discovered hormone secreted by adipocytes. Serum leptin concentrations increase in correlation with the percentage of body fat, but besides that little is known about the physiological actions of leptin in humans. In order to understand the role of leptin in severe malnutrition, in the present work 10 patients recently diagnosed with anorexia nervosa were studied both before and 2 months later, after partial weight recovery, and were compared with 18 normal-weight women as controls. Leptin was measured by a newly developed radioimmunoassay and both IGF-I and IGFBP-3 were measured by commercial radioimmunoassays. The mean (±SE) serum leptin concentrations (in μg/liter) were 18.1 ± 2.0 in control women with BMI of 21.1 ± 0.3, significantly higher (P <0.01) than that in the anorexia nervosa patients at diagnosis (2.2 ± 0.1, BMI 15.3 ± 0.6). These differences were also observed in IGF-I values (μg/liter) that were 228.0 ± 14.6 in controls and 157.4 ± 28.7 in anorexia nervosa patients (P <0.02). No differences were observed in IGF-BP3. After treatment, patients with anorexia nervosa experienced an increase in BMI (17.1 ± 0.5, P <0.0001 vs before) although they were still underweight. The partial recovery in weight led to a complete normalization of IGF-I levels (214.0 ± 21.0 μg/liter) and to an enhancement in leptin levels (3.3 ± 0.5 μg/liter; P <0.03 vs before treatment), though still lower than those in normal- weight women (P <0.05). Individually analyzed, a large dispersion was observed in control subjects, with leptin levels ranging from 5.5 to 38.7 μg/liter, while in all anorexia nervosa patients leptin levels were under 3 μg/liter. A treatment-induced increase in body weight led to an increase.",
author = "Casanueva, {Felipe F.} and Carlos Dieguez and Vera Popovic and Roberto Peino and Robert Considine and Caro, {Jose F.}",
year = "1997",
month = "4",
doi = "10.1006/bmme.1996.2564",
language = "English (US)",
volume = "60",
pages = "116--120",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery

AU - Casanueva, Felipe F.

AU - Dieguez, Carlos

AU - Popovic, Vera

AU - Peino, Roberto

AU - Considine, Robert

AU - Caro, Jose F.

PY - 1997/4

Y1 - 1997/4

N2 - Leptin, the product of the ob gene, is a recently discovered hormone secreted by adipocytes. Serum leptin concentrations increase in correlation with the percentage of body fat, but besides that little is known about the physiological actions of leptin in humans. In order to understand the role of leptin in severe malnutrition, in the present work 10 patients recently diagnosed with anorexia nervosa were studied both before and 2 months later, after partial weight recovery, and were compared with 18 normal-weight women as controls. Leptin was measured by a newly developed radioimmunoassay and both IGF-I and IGFBP-3 were measured by commercial radioimmunoassays. The mean (±SE) serum leptin concentrations (in μg/liter) were 18.1 ± 2.0 in control women with BMI of 21.1 ± 0.3, significantly higher (P <0.01) than that in the anorexia nervosa patients at diagnosis (2.2 ± 0.1, BMI 15.3 ± 0.6). These differences were also observed in IGF-I values (μg/liter) that were 228.0 ± 14.6 in controls and 157.4 ± 28.7 in anorexia nervosa patients (P <0.02). No differences were observed in IGF-BP3. After treatment, patients with anorexia nervosa experienced an increase in BMI (17.1 ± 0.5, P <0.0001 vs before) although they were still underweight. The partial recovery in weight led to a complete normalization of IGF-I levels (214.0 ± 21.0 μg/liter) and to an enhancement in leptin levels (3.3 ± 0.5 μg/liter; P <0.03 vs before treatment), though still lower than those in normal- weight women (P <0.05). Individually analyzed, a large dispersion was observed in control subjects, with leptin levels ranging from 5.5 to 38.7 μg/liter, while in all anorexia nervosa patients leptin levels were under 3 μg/liter. A treatment-induced increase in body weight led to an increase.

AB - Leptin, the product of the ob gene, is a recently discovered hormone secreted by adipocytes. Serum leptin concentrations increase in correlation with the percentage of body fat, but besides that little is known about the physiological actions of leptin in humans. In order to understand the role of leptin in severe malnutrition, in the present work 10 patients recently diagnosed with anorexia nervosa were studied both before and 2 months later, after partial weight recovery, and were compared with 18 normal-weight women as controls. Leptin was measured by a newly developed radioimmunoassay and both IGF-I and IGFBP-3 were measured by commercial radioimmunoassays. The mean (±SE) serum leptin concentrations (in μg/liter) were 18.1 ± 2.0 in control women with BMI of 21.1 ± 0.3, significantly higher (P <0.01) than that in the anorexia nervosa patients at diagnosis (2.2 ± 0.1, BMI 15.3 ± 0.6). These differences were also observed in IGF-I values (μg/liter) that were 228.0 ± 14.6 in controls and 157.4 ± 28.7 in anorexia nervosa patients (P <0.02). No differences were observed in IGF-BP3. After treatment, patients with anorexia nervosa experienced an increase in BMI (17.1 ± 0.5, P <0.0001 vs before) although they were still underweight. The partial recovery in weight led to a complete normalization of IGF-I levels (214.0 ± 21.0 μg/liter) and to an enhancement in leptin levels (3.3 ± 0.5 μg/liter; P <0.03 vs before treatment), though still lower than those in normal- weight women (P <0.05). Individually analyzed, a large dispersion was observed in control subjects, with leptin levels ranging from 5.5 to 38.7 μg/liter, while in all anorexia nervosa patients leptin levels were under 3 μg/liter. A treatment-induced increase in body weight led to an increase.

UR - http://www.scopus.com/inward/record.url?scp=0031128355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031128355&partnerID=8YFLogxK

U2 - 10.1006/bmme.1996.2564

DO - 10.1006/bmme.1996.2564

M3 - Article

VL - 60

SP - 116

EP - 120

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 2

ER -